Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion, has ...

The tricuspid valve is anatomically complex. It’s often called the “forgotten valve” because of its position in the back of ...

Aortic stenosis is fairly uncommon among young people, though not absent. In younger folks, the disease is typically caused by a congenital heart condition. As we age, calcium deposits can build up ...

CHANDIGARH: 87 years old, Tara Chand (name changed), resident of Panchkula, had undergone a non-surgical procedure for aortic ...

ACURATE neo2 TAVI achieves high success in severe bicuspid aortic stenosis, demonstrating strong 30-day safety and efficacy.

Tyler Scarborough, an 8-year-old boy with congenital heart disease, is the focus of a local military family's efforts to raise awareness about the disorder. Tyl ...

Women are often underdiagnosed and undertreated when it comes to heart disease, particularly conditions like aortic stenosis.

A high burden of heart valve diseases is driving its expansion. India’s transcatheter aortic valve replacement (TAVR) market ...

GlobalData’s latest report reveals that India accounted for only around 3 per cent of the market in APAC in 2024, due to ...

Edwards Lifesciences Corp.’s posted fourth quarter results slightly ahead of expectations, but indicated that the first quarter of 2025 might not be as bright. The company expects growth for both its ...